Free Trial

Sequoia Financial Advisors LLC Acquires New Holdings in Amdocs Limited $DOX

Amdocs logo with Computer and Technology background

Key Points

  • Sequoia Financial Advisors LLC has acquired a new stake of 8,931 shares in Amdocs Limited valued at approximately $815,000 during the second quarter.
  • Amdocs received a rating upgrade from Wall Street Zen from "hold" to "buy," while its stock currently has a consensus rating of "Moderate Buy" with a target price of $108.00.
  • The company announced a quarterly dividend of $0.527, resulting in a dividend yield of 2.5%, with a payout schedule for stockholders of record on September 30th.
  • Interested in Amdocs? Here are five stocks we like better.

Sequoia Financial Advisors LLC acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 8,931 shares of the technology company's stock, valued at approximately $815,000.

Other institutional investors also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC bought a new stake in Amdocs during the first quarter valued at about $27,000. Quarry LP boosted its position in Amdocs by 42.2% during the first quarter. Quarry LP now owns 391 shares of the technology company's stock valued at $36,000 after purchasing an additional 116 shares in the last quarter. Cullen Frost Bankers Inc. bought a new stake in Amdocs during the first quarter valued at about $39,000. SVB Wealth LLC bought a new stake in Amdocs during the first quarter valued at about $43,000. Finally, Geneos Wealth Management Inc. boosted its position in Amdocs by 213.9% during the first quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company's stock valued at $64,000 after purchasing an additional 477 shares in the last quarter. Institutional investors own 92.02% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a research report on Saturday, October 11th. Wolfe Research assumed coverage on Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating for the company. Finally, Weiss Ratings reiterated a "hold (c+)" rating on shares of Amdocs in a research note on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $108.00.

View Our Latest Research Report on Amdocs

Amdocs Trading Up 0.5%

Amdocs stock opened at $82.94 on Friday. The stock has a 50-day moving average of $84.41 and a two-hundred day moving average of $87.41. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.22 and a current ratio of 1.22. Amdocs Limited has a one year low of $78.61 and a one year high of $95.41. The stock has a market cap of $9.36 billion, a PE ratio of 16.82, a price-to-earnings-growth ratio of 1.38 and a beta of 0.51.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. During the same period last year, the business posted $1.62 earnings per share. The company's revenue for the quarter was down 8.4% compared to the same quarter last year. On average, research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is presently 42.80%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.